Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Phenomenex Combines Core-Shell Media and Axia™ Packing Technology

Published: Thursday, March 28, 2013
Last Updated: Thursday, March 28, 2013
Bookmark and Share
Delivers longer column lifetime, higher efficiencies, improved performance and high reproducibility.

Phenomenex Inc. has announced the availability of the Kinetex® Core-Shell media packed in Axia hardware for preparative HPLC and SFC in lab-scale purification.

Kinetex 5-micron particles in four phases - C18, XB-C18, Phenyl-Hexyl and PFP - are now offered in 21.2 mm ID Axia packing.

This marks the first time that core-shell media has been offered in the Phenomenex Axia preparative format, which delivers longer column lifetime, higher efficiencies, improved performance and high reproducibility, compared to conventionally packed columns for lab-scale prep chromatography.

Kinetex 5-micron core-shell media, introduced just a few months ago, is the largest particle in the family and delivers better performance than 5-micron fully porous offerings, with no increase in backpressure.

In fact, the new 5-micron media provides 60 to 90 percent higher average efficiencies compared to the same size fully porous columns with little to no method development.

The Phenomenex patented Axia packing and hardware technology, introduced in 2005, eliminates the drawbacks of traditional slurry packing, delivering uniform bed density and dramatic performance advances.

“This announcement brings together two award-winning technologies from Phenomenex,” explained J.T. Presley, brand manager for Phenomenex.

Presley continued, “Every Axia preparative column has been optimized for each packing media to improve column-to-column reproducibility and increase packing densities, resulting in higher efficiencies and prolonged column lifetime.”

Kinetex Core-Shell Technology in the Axia preparative format delivers a performance advantage to customers in pharmaceutical and natural products development, who can now use scalable core-shell solutions from analytical stage UHPLC or HPLC methods to purification.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Phenomenex Launches Spin-Off Technology Company Neoteryx LLC
Company will be spinning off a biological sampling focused company named Neoteryx LLC.
Saturday, July 19, 2014
Phenomenex Launches Newsletter for Food Chemists
The Dish is a regular newsletter specially written for the food testing industry.
Tuesday, April 15, 2014
Phenomenex Phree™ Phospholipid Removal Plates Win R&D 100 Award
Winners will be recognized at the R&D 100 Awards Banquet on November 7.
Monday, July 15, 2013
Phenomenex CEO Receives the Ellis Island Medal of Honor
Fasha Mahjoor was presented with an Ellis Island Medal of Honor, which ranks among the United States’ most prestigious awards.
Thursday, May 16, 2013
Phenomenex to Host AACC Workshop on LC/MS/MS for Clinical Diagnostics
Two-day, hands-on program to be held May 15 and 16.
Friday, May 10, 2013
Phenomenex Serves Growing Korean Market with Translated Website
Site also introduces a new industry-focused interface to help customers quickly find the best columns and methods for their needs.
Tuesday, May 07, 2013
Phenomenex Expert Selected to Present on Residues and Contaminants in Food
United Nations Agencies Fund Initiative to improve food safety in developing countries.
Wednesday, April 24, 2013
Phenomenex Launches Environmental Edge Newsletter
Environmental Edge newsletter will provide useful information on industry trends and tips.
Monday, April 08, 2013
Phenomenex Launches Innovative, Industry-Focused Websites
Company builds on award-winning web presence with new digital experience.
Friday, February 22, 2013
Phenomenex to Present Four Workshops at Pittcon 2013
Workshops will cover proteins, environmental contaminants, oligonucleotide therapeutics and core-shell technology.
Monday, December 17, 2012
Phenomenex Chiral Screening Services Now Offered in China
Collaboration with Chinese Academy of Sciences ensures fast, high-quality screening.
Wednesday, December 05, 2012
Phenomenex and ChromaDex® Announces Collaboration Agreement
New solutions to be presented at Association of Analytical Communities annual meeting next week.
Wednesday, October 03, 2012
Phenomenex Forms Phenova - A Certified Reference Materials Company
New company culminates the integration and expansion of Colorado-based Wibby Environmental.
Friday, August 24, 2012
Phenomenex Celebrates 30 Years
The company has grown from a one-man operation out of a garage to over 700 employees and a network of partners in 95 countries in only three decades.
Wednesday, June 13, 2012
Phenomenex Announces Direct Sales and Service for Sweden
Company expands its international team to serve Sweden.
Monday, January 30, 2012
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
How Baby’s Genes Influence Birth Weight And Later Life Disease
The large-scale study could help to target new ways of preventing and treating these diseases.
Genes Underlying Dogs’ Social Ability Revealed
The social ability of dogs is affected by genes that also seem to influence human behaviour, according to a new study from Linköping University in Sweden.
‘Cellbots’ Chase Down Cancer, Deliver Drugs Directly to Tumors
Programmable T cells shown to be versatile, precise, and powerful in lab studies.
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
C Dots Show Powerful Tumor Killing Effect
Nanoparticles known as Cornell dots, or C dots, have shown great promise as a therapeutic tool in the detection and treatment of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!